Scientists have uncovered a surprising overlap between cancer genetics and Alzheimer’s disease, involving mutations in the brain’s immune cells.
In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.
Join PanCAN on Thursday, June 25, at 11 a.m. PT / 2 p.m. ET, for a webinar focused on KRAS and pancreatic cancer. Our panel ...
The results, published May 5 in Nature Genetics, offer a new way to understand the molecular roots of cancer — an especially ...
Researchers at McGill University have discovered a centuries-old genetic mutation that helps to explain why some ...
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval. According to the National Cancer ...
Comprehensive maps of mutations in healthy and diseased gastric tissue give clues about how cancer arises and could inform early-detection strategies. Read the paper: The somatic mutation landscape of ...
An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at the University of Utah (the U) and Emory University, revealed that Black ...
The “Nobody Wants This” actor initially struggled with the decision but is now raising awareness for genetic testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results